Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03272217 |
Title | Atezolizumab With or Without Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Arjun Balar, MD |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Arizona at Dignity Health St. Joseph | Phoenix | Arizona | 85004 | United States | Details | |
Rush University Medical Center | Chicago | Illinois | 60612 | United States | Details | |
HealthPartners Institute | Minneapolis | Minnesota | 55440 | United States | Details | |
New York University Clinical Cancer Center | New York | New York | 10016 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
West Cancer Center University of Tennessee | Memphis | Tennessee | 38120 | United States | Details | |
Froedtert & The Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | United States | Details |